Table 1 Demographic and clinical characteristics of the study cohort.
Characteristic | Details | Mean (±SD) | Percentage % (n) |
|---|---|---|---|
Age at baseline | (years) | 45.26 ± 11.52 | |
Age at baseline distribution | 18–29 years | 8.35% (n = 53) | |
30–39 years | 25.19% (n = 160) | ||
40–49 years | 29.29% (n = 186) | ||
50–59 years | 26.62% (n = 169) | ||
60–69 years | 8.35% (n = 53) | ||
70–75 years | 1.42% (n = 9) | ||
76 years and above | 0.78% (n = 5) | ||
Gender distribution | Males | 42.04% (n = 267) | |
Females | 57.96% (n = 368) | ||
Age of onset of schizophrenia | (years) | 26.68 ± 8.01 | |
Duration of illness | (years) | 18.57 ± 11.5 | |
Illness duration categories | Less than 10 years | 26.29% (n = 167) | |
10–19 years | 30.71% (n = 195) | ||
20 years and above | 42.99% (n = 273) | ||
Duration of untreated psychosis | (years) | 1.84 ± 1.51 | |
Number of relapses | 18.09 ± 9.39 | ||
Relapse frequency categories | Fewer than 10 | 16.06% (n = 102) | |
10–19 relapses | 35.43% (n = 225) | ||
20 or more relapses | 48.51% (n = 308) | ||
Age at death | 58.97 ± 11.58 |
